1. Home
  2. RGNX vs NVEC Comparison

RGNX vs NVEC Comparison

Compare RGNX & NVEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • NVEC
  • Stock Information
  • Founded
  • RGNX 2008
  • NVEC 1989
  • Country
  • RGNX United States
  • NVEC United States
  • Employees
  • RGNX N/A
  • NVEC N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • NVEC Semiconductors
  • Sector
  • RGNX Health Care
  • NVEC Technology
  • Exchange
  • RGNX Nasdaq
  • NVEC Nasdaq
  • Market Cap
  • RGNX 424.8M
  • NVEC 370.0M
  • IPO Year
  • RGNX 2015
  • NVEC 1996
  • Fundamental
  • Price
  • RGNX $8.17
  • NVEC $61.59
  • Analyst Decision
  • RGNX Strong Buy
  • NVEC
  • Analyst Count
  • RGNX 8
  • NVEC 0
  • Target Price
  • RGNX $31.75
  • NVEC N/A
  • AVG Volume (30 Days)
  • RGNX 542.3K
  • NVEC 61.9K
  • Earning Date
  • RGNX 08-07-2025
  • NVEC 07-23-2025
  • Dividend Yield
  • RGNX N/A
  • NVEC 6.56%
  • EPS Growth
  • RGNX N/A
  • NVEC N/A
  • EPS
  • RGNX N/A
  • NVEC 3.00
  • Revenue
  • RGNX $156,718,000.00
  • NVEC $25,196,094.00
  • Revenue This Year
  • RGNX $327.08
  • NVEC N/A
  • Revenue Next Year
  • RGNX N/A
  • NVEC N/A
  • P/E Ratio
  • RGNX N/A
  • NVEC $19.93
  • Revenue Growth
  • RGNX 80.70
  • NVEC N/A
  • 52 Week Low
  • RGNX $5.04
  • NVEC $51.50
  • 52 Week High
  • RGNX $13.48
  • NVEC $88.50
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 45.17
  • NVEC 26.21
  • Support Level
  • RGNX $8.27
  • NVEC $59.19
  • Resistance Level
  • RGNX $9.32
  • NVEC $64.99
  • Average True Range (ATR)
  • RGNX 0.49
  • NVEC 2.78
  • MACD
  • RGNX -0.04
  • NVEC -1.71
  • Stochastic Oscillator
  • RGNX 20.16
  • NVEC 2.64

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About NVEC NVE Corporation

NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

Share on Social Networks: